Lv1
3 积分 2025-04-18 加入
[Consensus on the surgical management of benign gallbladder diseases(2021 edition)]
1个月前
已完结
Mastering Robotic Liver Resection: When Access Defines Success - Insights from the French FRIES-ACHBPT-2024 Cohort
1个月前
已完结
Mastering Robotic Liver Resection
1个月前
已关闭
Mastering Robotic Liver Resection
1个月前
已关闭
Lactate modulates CD4+ T-cell polarization and induces an immunosuppressive environment, which sustains prostate carcinoma progression via TLR8/miR21 axis
5个月前
已完结
983P Updated safety and efficacy of ABSK-011 in advanced hepatocellular carcinoma (aHCC) with FGF19 overexpression from a phase I study
6个月前
已关闭
Editorial: Predictive Factors and Survival Outcome of Conversion Therapy for Unresectable Hepatocellular Carcinoma Patients Receiving Atezolizumab and Bevacizumab: Comparative Analysis of Conversion, Partial Response and Complete Response Patients. Authors' Reply
6个月前
已完结
Lenvatinib plus pembrolizumab versus lenvatinib plus placebo for advanced hepatocellular carcinoma (LEAP-002): a randomised, double-blind, phase 3 trial
6个月前
已完结
Interventional Oncology Meets Immuno-oncology: Combination Therapies for Hepatocellular Carcinoma
6个月前
已完结
Preoperative transarterial chemoembolization (TACE) + liver resection versus upfront liver resection for large hepatocellular carcinoma (≥5 cm): a systematic review and meta-analysis
6个月前
已完结
皖公网安备34019202002308
